Prostate health index (phi) and prostate cancer antigen 3 (PCA3) significantly improve diagnostic accuracy in patients undergoing prostate biopsy (Q46632925)

From Wikidata

Jump to navigation Jump to search

scientific article published on 20 July 2012

Language	Label	Description	Also known as
English	Prostate health index (phi) and prostate cancer antigen 3 (PCA3) significantly improve diagnostic accuracy in patients undergoing prostate biopsy	scientific article published on 20 July 2012

Statements

scholarly article

1 reference

Europe PubMed Central

23 December 2017

http://europepmc.org/abstract/MED/22821756

Prostate health index (phi) and prostate cancer antigen 3 (PCA3) significantly improve diagnostic accuracy in patients undergoing prostate biopsy (English)

1 reference

Europe PubMed Central

23 December 2017

http://europepmc.org/abstract/MED/22821756

2

1 reference

Europe PubMed Central

23 December 2017

http://europepmc.org/abstract/MED/22821756

3

1 reference

Europe PubMed Central

23 December 2017

http://europepmc.org/abstract/MED/22821756

Riccardo Autorino

4

object named as

Riccardo Autorino

1 reference

Europe PubMed Central

23 December 2017

author name string

Sisto Perdonà

1

1 reference

Europe PubMed Central

23 December 2017

http://europepmc.org/abstract/MED/22821756

Ada Marino

5

1 reference

Europe PubMed Central

23 December 2017

http://europepmc.org/abstract/MED/22821756

Claudia Mazzarella

6

1 reference

Europe PubMed Central

23 December 2017

http://europepmc.org/abstract/MED/22821756

Giuseppe Perruolo

7

1 reference

Europe PubMed Central

23 December 2017

http://europepmc.org/abstract/MED/22821756

Michele Longo

8

1 reference

Europe PubMed Central

23 December 2017

http://europepmc.org/abstract/MED/22821756

Rosa Spinelli

9

1 reference

Europe PubMed Central

23 December 2017

http://europepmc.org/abstract/MED/22821756

Giuseppe Di Lorenzo

10

1 reference

Europe PubMed Central

23 December 2017

http://europepmc.org/abstract/MED/22821756

Andrea Oliva

11

1 reference

Europe PubMed Central

23 December 2017

http://europepmc.org/abstract/MED/22821756

Marco De Sio

12

1 reference

Europe PubMed Central

23 December 2017

http://europepmc.org/abstract/MED/22821756

Rocco Damiano

13

1 reference

Europe PubMed Central

23 December 2017

http://europepmc.org/abstract/MED/22821756

Vincenzo Altieri

14

1 reference

Europe PubMed Central

23 December 2017

http://europepmc.org/abstract/MED/22821756

Daniela Terracciano

15

1 reference

Europe PubMed Central

23 December 2017

http://europepmc.org/abstract/MED/22821756

publication date

20 July 2012

1 reference

Europe PubMed Central

23 December 2017

http://europepmc.org/abstract/MED/22821756

1 reference

Europe PubMed Central

23 December 2017

http://europepmc.org/abstract/MED/22821756

73

1 reference

Europe PubMed Central

23 December 2017

http://europepmc.org/abstract/MED/22821756

3

1 reference

Europe PubMed Central

23 December 2017

http://europepmc.org/abstract/MED/22821756

227-235

1 reference

Europe PubMed Central

23 December 2017

http://europepmc.org/abstract/MED/22821756

PCA3: from basic molecular science to the clinical lab.

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22561

21 January 2018

Tumour markers in prostate cancer III: biomarkers in urine.

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22561

21 January 2018

Prostate-specific antigen (PSA) isoform p2PSA in combination with total PSA and free PSA improves diagnostic accuracy in prostate cancer detection.

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22561

21 January 2018

Clinical utility of the PCA3 urine assay in European men scheduled for repeat biopsy

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22561

21 January 2018

The prostate cancer gene 3 (PCA3) urine test in men with previous negative biopsies: does free-to-total prostate-specific antigen ratio influence the performance of the PCA3 score in predicting positive biopsies?

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22561

21 January 2018

Pro-prostate-specific antigen measurements in serum and tissue are associated with treatment necessity among men enrolled in expectant management for prostate cancer

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22561

21 January 2018

ProPSA and diagnostic biopsy tissue DNA content combination improves accuracy to predict need for prostate cancer treatment among men enrolled in an active surveillance program

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22561

21 January 2018

Predicting prostate biopsy outcome: prostate health index (phi) and prostate cancer antigen 3 (PCA3) are useful biomarkers.

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22561

21 January 2018

Standard operating procedures for serum and plasma collection: early detection research network consensus statement standard operating procedure integration working group

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22561

21 January 2018

APTIMA PCA3 molecular urine test: development of a method to aid in the diagnosis of prostate cancer

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22561

21 January 2018

Extended sampling at first biopsy improves cancer detection rate: results of a prospective, randomized trial comparing 12 versus 18-core prostate biopsy

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22561

21 January 2018

Accuracy of PCA3 measurement in predicting short-term biopsy progression in an active surveillance program

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22561

21 January 2018

Sample size determination for diagnostic accuracy studies involving binormal ROC curve indices

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22561

21 January 2018

Internal validation of predictive models: efficiency of some procedures for logistic regression analysis.

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22561

21 January 2018

Decision curve analysis: a novel method for evaluating prediction models

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22561

21 January 2018

Tumor markers in prostate cancer I: blood-based markers

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22561

21 January 2018

Urine biomarkers in prostate cancer

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22561

21 January 2018

Contemporary role of prostate cancer antigen 3 in the management of prostate cancer.

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22561

21 January 2018

Clinical evaluation of the PCA3 assay in guiding initial biopsy decisions

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22561

21 January 2018

Contemporary role of prostate cancer gene 3 in the management of prostate cancer.

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22561

21 January 2018

A panel of kallikrein markers can predict outcome of prostate biopsy following clinical work-up: an independent validation study from the European Randomized Study of Prostate Cancer screening, France

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22561

21 January 2018

A panel of TMPRSS2:ERG fusion transcript markers for urine-based prostate cancer detection with high specificity and sensitivity

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22561

21 January 2018

A three-gene panel on urine increases PSA specificity in the detection of prostate cancer.

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22561

21 January 2018

Prostate cancer detection in the "grey area" of prostate-specific antigen below 10 ng/ml: head-to-head comparison of the updated PCPT calculator and Chun's nomogram, two risk estimators incorporating prostate cancer antigen 3.

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22561

21 January 2018

A [-2]proPSA-based artificial neural network significantly improves differentiation between prostate cancer and benign prostatic diseases.

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22561

21 January 2018

Identifiers

10.1002/PROS.22561

1 reference

Europe PubMed Central

23 December 2017

http://europepmc.org/abstract/MED/22821756

1 reference

Europe PubMed Central

23 December 2017

http://europepmc.org/abstract/MED/22821756

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46632925&oldid=2123142920"